Who Owns GANX?

Gain Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$1.86

-0.09 (-4.36%)

Market Cap

$82.4M

Shares Outstanding

42,241,900

Institutional Holders

33

Total Inst. Value

$4.3M

% of Float Held

6.8%

QoQ Holder Change

+8

Institutional data as of Q1 2025

New Positions

11

Closed Positions

3

Increased

10

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1DME Capital Management, LP$1.1M566,130
2GEODE CAPITAL MANAGEMENT, LLC$538K282,211
3VANGUARD GROUP INC$486K254,990
4MARSHALL WACE, LLP$374K196,026
5Dauntless Investment Group, LLCNew$240K125,584
6NORTHERN TRUST CORP$191K100,170
7MORGAN STANLEY$189K99,795
8SUSQUEHANNA INTERNATIONAL GROUP, LLP$164K85,958
9BlackRock, Inc.$161K84,407
10STATE STREET CORP$135K71,137

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold GANX?

As of Q1 2025, 33 institutional investors report holding GANX (Gain Therapeutics, Inc.) in their 13F filings.

What percentage of Gain Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 6.8% of Gain Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most GANX?

The largest institutional holder of GANX is DME Capital Management, LP with $1.1M in shares.

Are institutions buying or selling GANX?

This quarter, 11 institutions opened new positions in GANX and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.